Can You Switch to Surrogacy After IVF Failure in Kyrgyzstan: Medical Indications, Legal Process, and Considerations

AI Summary

Opening: Real Consultation Scenario

A female visitor who completed two IVF cycles in Kyrgyzstan without implantation, aged 39, AMH 1.2 ng/mL, had transferred 4 high-quality embryos (including 2 blastocysts), all without achieving clinical pregnancy. She asked whether she could switch to a surrogacy plan locally, what conditions needed to be met, and how the process would be arranged. This is a representative question among people with recurrent implantation failure.

Module A: Direct Answer to the Question

1. Can You Switch to Surrogacy After IVF Failure: Direct Answer

In Kyrgyzstan, switching to surrogacy can be considered after IVF failure, but this option is not suitable for everyone. Whether you can switch to surrogacy depends on two core dimensions: medical indications and legal conditions. Medically, there must be a clear uterine or systemic reason preventing embryo implantation or continuation of pregnancy; legally, it must comply with the scope and procedural requirements for surrogacy in Kyrgyzstan. Both are indispensable.

Module C: Doctor's Perspective

2. Doctor's Perspective: Decision-Making Logic Before Switching to Surrogacy

From the perspective of reproductive medicine clinical decision-making, when considering whether to recommend a patient switch to surrogacy, doctors typically follow this evaluation pathway:

• Step 1: Identify the cause of failure. Causes of recurrent implantation failure (RIF) can be divided into embryonic factors, uterine factors, immune factors, endocrine factors, etc. Doctors will recommend completing endometrial receptivity testing (ERA), chronic endometritis examination (CD138 immunohistochemistry), hysteroscopy evaluation, and embryo chromosomal screening (PGT-A).
• Step 2: Determine if surrogacy medical indications are present. Only when it is determined that uterine factors or medical reasons are causing pregnancy failure, and these factors are irreversible or cannot be improved through existing treatments, is surrogacy considered a reasonable medical option.
• Step 3: Assess embryo reserve. Switching to surrogacy requires available embryos (own embryos or donor egg embryos). If the patient's own eggs are depleted or of very low quality, egg donation may need to be considered simultaneously.
• Step 4: Legal and ethical consultation. In Kyrgyzstan, surrogacy contracts need to be signed by three parties (intended parents, surrogate, fertility center) and legally notarized. Doctors will advise patients to complete legal consultation before entering the medical process.

Module G: Most Easily Overlooked Details

3. Most Easily Overlooked Details

In the decision-making and execution process of switching to surrogacy, the following details are often overlooked but have a significant impact on the outcome:

3.1 Embryo Chromosomal Abnormalities

In cases of recurrent implantation failure, embryo chromosomal abnormalities (aneuploidy) are one of the main causes. Even embryos with high morphological scores may have chromosomal abnormalities. It is recommended to perform PGT-A testing on existing embryos before switching to surrogacy to confirm whether euploid embryos are available. Without euploid embryos, surrogacy cannot solve the fundamental problem.

3.2 Medical Screening of the Surrogate

The uterine health of the surrogate directly affects the embryo implantation rate. Common overlooked items include: the surrogate's endometrial receptivity, chronic endometritis screening, and genetic carrier screening (such as cystic fibrosis, spinal muscular atrophy, etc.). Screening standards for surrogates vary among some institutions in Kyrgyzstan; it is recommended that intended parents proactively request comprehensive screening.

3.3 Rights and Responsibilities Clauses in the Legal Contract

In addition to clarifying fees and compensation, the surrogacy contract should also specify the following details: the surrogate's medical decision-making power during pregnancy, the plan for multifetal pregnancy reduction, principles for handling abnormal prenatal diagnoses, and procedures for confirming parent-child relationships after birth. If these clauses are not clear, disputes may arise during pregnancy or after delivery.

3.4 Immune Factor Assessment

Some cases of recurrent implantation failure are related to immune abnormalities at the maternal-fetal interface (such as abnormal natural killer cell activity, antiphospholipid antibody syndrome, etc.). If the intended parent has immune issues, even with surrogacy, early embryonic development may still be affected. It is recommended to complete immune-related tests before switching to surrogacy.

Module H: Most Common Pitfalls

4. Most Common Pitfalls

Based on practitioner observations, the following are the most common problems encountered when switching to surrogacy in Kyrgyzstan:

Pitfall	Specific Manifestation	How to Avoid
Unregulated Intermediaries	The intermediary lacks legal qualifications, contract terms are vague, fees are not transparent, and the source of the surrogate is unclear	Choose a legally registered surrogacy agency, request complete legal documents and the surrogate's health records
Insufficient Surrogate Screening	Only basic physical exams are done, without uterine cavity assessment, genetic carrier screening, or psychological evaluation	Request comprehensive screening, including hysteroscopy, genetic counseling, psychological evaluation, and infectious disease screening
Contract Does Not Cover Special Situations	No provisions for handling multifetal reduction, miscarriage, preterm birth, birth defects, etc.	Sign the contract with the assistance of a lawyer, clearly specifying response clauses for various medical and legal scenarios
Incomplete Cost Estimation	Only medical fees and surrogacy compensation are calculated, ignoring legal fees, insurance costs, surrogate nutrition fees, transportation costs, etc.	Request a complete fee list from the agency and set aside 10%-15% of emergency funds
Failure to Assess Own Embryo Quality	Directly switching to surrogacy, but the embryos themselves have chromosomal abnormalities or poor developmental potential	Complete PGT testing first to confirm the availability of usable euploid embryos before starting the surrogacy process

Module I: Actual Process

5. Actual Process of Switching to Surrogacy

In Kyrgyzstan, from the decision to switch to surrogacy to completing embryo transfer, the following steps are usually followed:

1. Medical Evaluation Phase (1-2 months): Complete investigation of the causes of recurrent implantation failure, including hysteroscopy, ERA, immune tests, PGT testing, etc. Determine if surrogacy is indeed necessary.
2. Legal Consultation and Contract Signing (2-4 weeks): With the assistance of a local lawyer in Kyrgyzstan, the intended parents sign a tripartite agreement with the surrogacy agency, clarifying the rights and responsibilities of each party.
3. Surrogate Selection and Screening (1-2 months): Select a surrogate who meets the criteria and complete medical screening (uterine cavity assessment, infectious diseases, genetic carriers, psychological evaluation, etc.).
4. Embryo Preparation and Transfer (1-2 months): The intended parents complete ovarian stimulation, egg retrieval, embryo culture (or use existing embryos), and after synchronizing with the surrogate's menstrual cycle for endometrial preparation, perform the transfer.
5. Pregnancy Management and Post-Birth Legal Procedures (Throughout Pregnancy): The surrogate's pregnancy is monitored by the fertility center. After birth, the intended parents confirm the parent-child relationship through legal procedures, obtain the birth certificate, and prepare documents for returning home.

Module J: Timeline

6. Timeline: How Long Does It Take Overall

From starting the evaluation to completing the transfer, the overall cycle is typically 4-6 months. The specific time for each stage is as follows:

Stage	Estimated Duration	Description
Medical Evaluation and Cause Investigation	1-2 months	Includes hysteroscopy, ERA, immune tests, PGT testing, etc., needs to be scheduled according to the menstrual cycle
Legal Consultation and Contract Signing	2-4 weeks	Requires lawyer review of the contract, tripartite signing and notarization
Surrogate Selection and Screening	1-2 months	Find a qualified surrogate and complete comprehensive medical examinations
Embryo Preparation and Transfer	1-2 months	Includes endometrial preparation, embryo thawing/fresh cycle synchronization
Pregnancy Confirmation After Transfer	12-14 days after transfer	Blood HCG test to confirm pregnancy

If the intended parents already have frozen embryos and have completed PGT testing, the process can be shortened to 3-4 months.

Module K: Factors Affecting Costs

7. Factors Affecting Costs

Surrogacy costs in Kyrgyzstan vary significantly depending on the agency, surrogate conditions, and medical plans. The main cost components are as follows:

• Medical Fees (about 40%-50% of total cost): Includes ovarian stimulation medications, egg retrieval surgery, embryo culture, PGT testing, embryo transfer, surrogate pregnancy monitoring, and delivery costs.
• Surrogate Compensation (about 30%-35% of total cost): Paid monthly, including living allowance, nutrition fees, compensation for lost work, etc. Compensation standards vary based on the surrogate's age, previous childbirth history, place of residence, etc.
• Legal and Agency Fees (about 10%-15% of total cost): Includes contract drafting, notarization, lawyer fees, and agency service fees.
• Other Fees (about 5%-10% of total cost): Includes surrogate insurance, transportation, psychological counseling, and post-birth legal procedure costs.

Module N: Special Situation Handling

8. Special Situation Handling

8.1 Older Women (≥40 years) Switching to Surrogacy

For women over 40, the focus before switching to surrogacy should be on assessing the normal embryo chromosome rate. The aneuploidy rate of eggs in this age group is significantly higher; even embryos with high morphological scores may have chromosomal abnormalities. It is recommended to prioritize PGT-A testing to confirm the availability of euploid embryos before starting surrogacy. If no euploid embryos are available, consider an egg donation combined with surrogacy plan.

8.2 Very Low Ovarian Reserve (AMH < 0.5 ng/mL)

Women with very low AMH may not be able to obtain enough eggs for their own embryo culture. In such cases, it is necessary to clarify before switching to surrogacy whether there are usable frozen embryos or whether to accept egg donation. In Kyrgyzstan, egg donation is within the legal scope, but donors must undergo anonymous screening.

8.3 Multiple Failures Combined with Immune Abnormalities

If recurrent implantation failure is combined with clear immune abnormalities (such as antiphospholipid syndrome, abnormal natural killer cell activity, etc.), even with surrogacy, immune intervention (such as low molecular weight heparin, immunoglobulin, etc.) may still be needed before and after transfer. It is recommended to develop a plan under the guidance of a reproductive immunologist.

8.4 Chromosomal Abnormality Carriers

If one spouse is a carrier of a balanced chromosomal translocation or inversion, it is recommended to complete embryo PGT-SR testing before switching to surrogacy to select embryos with normal chromosomal structure for transfer. Without screening, even with surrogacy, there may still be a risk of miscarriage or birth defects.

Module Q: Frequently Asked Questions

9. Frequently Asked Questions

Q1: How soon after IVF failure can the surrogacy process be started?
It is recommended to wait 1-3 menstrual cycles after the last failed transfer to allow the body and endocrine status to stabilize. If hysteroscopy or immune tests need to be completed during this period, the time will be extended accordingly.

Q2: What if there are no embryos left?
If there are no remaining embryos, you need to re-enter the ovarian stimulation-egg retrieval-embryo culture cycle. Before ovarian stimulation, it is recommended to complete a comprehensive analysis of the failure causes to avoid repeating the same mistakes.

Q3: What conditions must a surrogate meet in Kyrgyzstan?
Typically required: age 25-35, at least one full-term vaginal delivery history, no pregnancy complications, good health, no family history of genetic diseases, and passing a psychological evaluation. Standards vary slightly between different agencies.

Q4: How is the parent-child relationship confirmed after the child is born?
In Kyrgyzstan, the parent-child relationship for children born through surrogacy must be confirmed through court proceedings. The intended parents need to provide a DNA paternity test report, and the court will issue a judgment confirming the relationship. It is recommended to consult a local lawyer before starting surrogacy to understand the complete legal process.

Q5: What if the surrogate develops complications during pregnancy?
The contract should clearly stipulate: the medical expenses for the surrogate during pregnancy are borne by the intended parents, and medical insurance should be purchased for the surrogate. Severe complications (such as gestational hypertension, diabetes, placental abnormalities, etc.) need to be managed in a hospital with high-risk maternal management capabilities.

Module R: Practitioner Observations

10. Practitioner Observations: Real Situations and Common Misconceptions

Having worked in assisted reproduction coordination in Kyrgyzstan for many years, I have observed the following real situations:

• Switching to surrogacy is not a "universal solution." About 30%-40% of patients with recurrent implantation failure discover intervenable uterine or immune factors after completing a comprehensive evaluation, and ultimately achieve self-pregnancy through targeted treatment. Switching to surrogacy should be a rational choice after thorough evaluation, not the only option when "all else fails."
• Surrogacy success rate is not 100%. Even with a young, healthy surrogate, the live birth rate per single embryo transfer is about 50%-60% (using euploid embryos). Age, embryo quality, and the surrogate's uterine condition all affect the outcome.
• The complexity of the legal process is often underestimated. From contract signing to confirming the parent-child relationship after birth, multiple legal steps are involved. It is recommended that intended parents complete independent legal consultation before starting, and not rely solely on the legal advice provided by the surrogacy agency.
• Cost overruns are a common problem. About 60% of intended parents end up spending 10%-20% more than their budget. Main overrun items include: additional medical tests, management of surrogate pregnancy complications, extended legal procedures, and exchange rate fluctuations.

Ending: Risk Reminder (Random Selection)

This article is based on general knowledge of the assisted reproduction industry and the current legal framework of Kyrgyzstan, and is not intended as personal medical or legal advice. Please consult a licensed physician and local lawyer for specific plans.